IFN-alpha kinoid: Preliminary Phase I/II data

Preliminary data from the double-blind, placebo-controlled, dose-escalation, European Phase I/II IFN-K-001 trial in 20 patients

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE